Evaluation of Different Risk Factors for Early Diagnosis of Diabetes Mellitus

Similar documents
CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION

Management of Gestational Diabetes

1114 La Revue de Santé de la Méditerranée orientale, Vol. 9, N o 5/6, 2003

Biomarkers and undiagnosed disease

Screening and Diagnosis of Diabetes Mellitus in Taiwan

Prevalence of Diabetes Mellitus and Pre-Diabetes in the Philippines: A Sub-study of the 7 th National Nutrition and Health Survey (2008)

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Prevalence of Diabetes Mellitus among Non-Bahraini Workers Registered in Primary Health Care in Bahrain

International Journal of Health Sciences and Research ISSN:

Diabetes mellitus is diagnosed and characterized by chronic hyperglycemia. The effects of

Standards of Medical Care in Diabetes 2016

Current Trends in Diagnosis and Management of Gestational Diabetes

Prevalence of Impaired Glucose Tolerance and Diabetes among patients with Impaired Fasting Blood Sugar in Seria Health Centre.

Abdominal volume index and conicity index in predicting metabolic abnormalities in young women of different socioeconomic class

Diabetes: Staying Two Steps Ahead. The prevalence of diabetes is increasing. What causes Type 2 diabetes?

Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes

A Study of Gestational Diabetes in Patients in a Tertiary Care Hospital in Hyderabad Telangana State, India

Gita Shafiee. MD, MPH Tehran University of Medical Sciences (TUMS)

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

2010 ADA Guidelines: 1. Diagnostic Criteria for DM 2. Categories of increased risk of DM. Gerti Tashko, M.D. DM Journal Club 1/21/2010

Primary Prevention of T2DM. KW Chan Endocrine & Diabetes Team Department of M&G, PMH 22 March 2009

during pregnancy. any degree of impaired glucose intolerance 11/19/2012 Prevalence & Diagnosis of Gestational Diabetes

ABSTRACT: 9 DOES SOY CONSUMPTION HAVE AN EFFECT ON HYPERTENSION IN LOW-INCOME RURAL SOUTH AFRICAN WOMEN?

G. W. Katulanda 1, P. Katulanda 2,3,4, C. Dematapitiya 2, H. A. Dissanayake 2*, S. Wijeratne 5, M. H. R. Sheriff 2 and D. R.

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE

An Overview on Cardiovascular Risks Definitions by Using Survival Analysis Techniques-Tehran Lipid and Glucose Study: 13-Year Follow-Up Outcomes

Implementing Type 2 Diabetes Prevention Programmes

Type 2 Diabetes Mellitus 2011

ARTICLE. W. P. Jia & C. Pang & L. Chen & Y. Q. Bao & J. X. Lu & H. J. Lu & J. L. Tang & Y. M. Wu & Y. H. Zuo & S. Y. Jiang & K. S.

Early diagnosis, early treatment and the new diagnostic criteria of diabetes mellitus

Screening for gestational diabetes mellitus: the Sri Lankan experience

Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China

NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes

Guidelines on cardiovascular risk assessment and management

Original Article. Keiko KOHNO 1), Kazuhiko HOSHI 1), Motoi TAKIZAWA 1), Takashi KANEKO 2), and Shuji HIRATA 1)

METHODS AND MATERIALS

Population: All participants Number of Obs: Variable # Sas Name: Sas Label: Categories: Variable # Sas Name: F80VNUM. Sas Label: Categories:

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Gestational Diabetes. Gestational Diabetes:

Epidemiology and Prevention

The Metabolic Syndrome: Is It A Valid Concept? YES

Evaluation of first trimester fasting blood glucose as a predictor of gestational diabetes mellitus

WORLDWIDE, THE PREVAlence

Prevalence of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus

Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome

Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico

Why Do We Care About Prediabetes?

Vipul Lakhani, MD Oregon Medical Group Endocrinology

Cardiovascular Disease After Spinal Cord Injury: Achieving Best Practice. Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010

Nutrition and Medicine, 2006 Tufts University School of Medicine Nutrition and Type 2 Diabetes: Learning Objectives

Taking Steps to Control and Prevent Diabetes Zaida Belendez, ND, RN

V. N. Karazin Kharkiv National University Department of internal medicine Golubkina E.O., ass. of prof., Shanina I. V., ass. of prof.

Research Article Incidence of Prediabetes and Type 2 Diabetes among People Aged over 20 Years in Ahvaz: A 5-Year Perspective Study ( )

Depok-Indonesia STEPS Survey 2003

A CROSS SECTIONAL STUDY OF RELATIONSHIP OF OBESITY INDICES WITH BLOOD PRESSURE AND BLOOD GLUCOSE LEVEL IN YOUNG ADULT MEDICAL STUDENTS

A CLINICAL STUDY OF GESTATIONAL DIABETES MELLITUS IN A TEACHING HOSPITAL IN KERALA Baiju Sam Jacob 1, Girija Devi K 2, V.

SCREENING FOR DIABETES IN THE FIRST TRIMESTER: WHY & HOW? Jillian Coolen, MD FRCSC DCPNS Spring Conference April 21, 2016

Counseling and Long-term Follow up After Gestational Disorders

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Diabetes, Diet and SMI: How can we make a difference?

Diabetes Management and Considerations for the Indian Culture

PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS

Incidence of type 2 diabetes by HbA 1c and OGTT: the Isfahan Diabetes Prevention Study

Mafauzy Mohamed, Than Winn, GR Lekhraj Rampal*, Abdul Rashid AR, Mustaffa BE

6/10/2016. Hui-Chun Hsu

Addressing Addressing Challenges in Type 2 Challenges in Type 2 Diabetes Diabetes Speaker:

Association of hypothyroidism with metabolic syndrome - A case- control study

Diabetes Related Disclosures

Bisphenol A and the risk of cardiometabolic disorders: a systematic review with metaanalysis of the epidemiological evidence

Introduction 1 CHAPTER I INTRODUCTION

Diabetes Diagnosis 2011 Does your patient have diabetes?

programme. The DE-PLAN follow up.

The State of Play of Diabetes Indicators

Investigating the diagnosis of gestational diabetes

Diabetes Mellitus Type 2 Evidence-Based Drivers

DIABETES RISK CALCULATOR: A Simple Tool for Detecting Undiagnosed Diabetes and Prediabetes

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

Key words: Ageing, Cardiovascular disease, Epidemiology, Insulin resistance

Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with

Gestational Diabetes- Tonga s Experiences, Screening & Challenges. Dr. Maake Tupou, Obstetrics & Gynaecology Unit, Vaiola Hospital, Tonga.

Optimizing Postpartum Maternal Health to Prevent Chronic Diseases

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

The Diabetes Link to Heart Disease

Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study. Arab Medical University. Benghazi, Libya

Prevalence of and Risk Factors for Type 2 Diabetes Mellitus in Hyperlipidemia in China

1080 La Revue de Santé de la Méditerranée orientale, Vol. 14, N o 5, 2008

COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)

An individual with undiagnosed diabetes is someone whose diabetes has not. Undiagnosed diabetes: Does it matter? Research Recherche

METABOLIC SYNDROME IN TYPE-2 DIABETES MELLITUS

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS

Chapter Two. The study of Acanthosis nigricans

DIABETES PREVALENCE: A COMPARISON BETWEEN URBAN AND RURAL AREAS OF BANGLADESH

Association of serum adipose triglyceride lipase levels with obesity and diabetes

Downloaded from irje.tums.ac.ir at 20:01 IRDT on Friday March 22nd 2019

General Outline. General Outline. Pathogenesis of Metabolic Dysfunction in Sleep Apnea: The Role of Sleep Fragmentation and Intermittent Hypoxemia

Transcription:

IJMS Vol 29, No 1, March 2004 Original Article Evaluation of Different Risk Factors for Early Diagnosis of Diabetes Mellitus S. Habibi Moeini, P. Mirmiran, Y. Mehrabi, F. Azizi Abstract Background: The efficacy of various screening variables in detection of diabetes mellitus (DM) is unclear. Objective: To determine the efficacy of various diagnostic tests for type 2 DM. Methods: 1021 inhabitants of Hakimieh district of Tehran aged between 30 and 75 years were studied. Known cases of diabetes and those with factors influencing glucose tolerance test were excluded. Age, sex, family history of DM, history of gestational diabetes, body mass index (BMI), waist hip ratio, blood pressure, urine glucose 2 hours after breakfast, fasting plasma glucose (FPG) and serum glucose 2 hours after consumption of 75 gm glucose (2hPG) were determined. Sensitivity, specificity and predictive values of each of these variables in comparison to WHO criteria were assessed. Results: According to WHO criteria, 5.9% of the population had undiagnosed diabetes. This rate declined to 3.8 % when employing the latest American Diabetes Association (ADA) diagnostic criteria (FPG 126 mg/dl). 88% of these newly diagnosed diabetics were diagnosed by means of 2hPG of whom 15% were classified within the normal group by ADA criteria. The 2hPG test showed higher reproducibility than the FPG test (84% vs. 67%). Truncal obesity had the maximum sensitivity (67%) and glycosuria had the highest specificity (99%). Therefore, none of these indices could be considered as a reliable screening method. Regarding 87% sensitivity and 54% specificity, a single method can be used as a proper screening test for men under 50 years of age. In women of similar age, two positive risk factors might be recruited as a useful screening method. However, the sensitivity and specificity approximated 82% and 59%, respectively. Endocrine and Metabolism Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran. Correspondence: F. Azizi, MD, P.O. Box 19395-4763, Tehran, Iran Tel: +98-21-2402463 E-mail: azizi@erc.ac.ir Conclusion: 2hPG is the most reliable test for diagnosis of DM. Screening via risk factors is not useful in people older than 50 years. Individuals aged <50 years, men with at least one positive risk factor and women with a minimum of two positive risk factors, are appropriate candidates for final diagnosis by glucose tolerance test. Iran J Med Sci 2004; 29(1):21-25. Keywords Diabetes Mellitus Diagnosis Screening 21

S. Habibi Moeini, P. Mirmiran, Y. Mehrabi, F Azizi Introduction N umerous complications of diabetes mellitus (DM) account for the major causes of disability, organic defects and mortality. 1-6 Epidemiological studies have shown a prevalence of 5% to 8% DM in people over 30 years of age in some cities and in rural areas of Tehran province. 7-9 The prevalence of impaired glucose tolerance (IGT) is roughly the same as that of DM. 9,10 Thus, 16% to 20% of the populations over 30 years are expected to show abnormal glucose tolerance tests. In Iran, a national program for controlling DM and screening of high risk groups by health-care personnel has been implemented. 10 Several methods are used for diagnosis of DM of which the most important is the oral glucose tolerance test (OGTT), that is, the measurement of blood glucose 2 hours after consumption of 75 gr of glucose given orally. 11 However, conducting OGTT in large populations is costly and cumbersome. In addition, OGTT is not available in all Iranian health networks. Hence, it would be beneficial to compare various screening methods and choose the most practical and available tests in health-care centers, to ensure the success of nation-wide control program. The aim of the present study was to evaluate, as a cost beneficial procedure, the value of various diagnostic tests for diagnosis of DM in the population of a district in Tehran, in order to detect variable(s) for practical screening of DM. Patients and methods Individuals between 30 and 75 years of age were selected from Hakimieh district in Northeast Tehran, by cluster sampling. Assuming 5% prevalence of unknown diabetes, 90% confidence level and 1% maximum error, 1021 cases were selected from 25000 inhabitants of the district. The exclusion criteriae were known cases of DM, patients who had been bedridden for any reasons, those afflicted by systemic diseases or infections and individuals receiving glucocorticoids or oral contraceptives. On the first day, urine specimens were collected for glucose measurement 2 hrs after regular breakfast. Personal medical and family histories of DM were collected by questionnaires. Positive history of gestational diabetes mellitus (GDM) was considered if a woman gave a history of GDM and history of having a child with a birth weight >4000 g. Weight and height were measured. Supine arterial blood pressure, waist and hip circumferences were determined. Truncal obesity was defined according to weightheight ratio (WHR) gold standard and was 0.8 in women and 0.95 in men. On the next day, OGTT was performed. At least 3 days prior to GTT, each individual had a diet containing a minimum of 150 g of carbohydrates and a regular physical activity. Before testing, patients fasted overnight for 10 16 hrs and received a glucose solution (1.75 grams anhydrous glucose/kg of body weight). On the day of the experiment, a venous blood sample was taken to obtain fasting blood glucose level (FBG). Then the patient was given an oral glucose solution containing 75 g of glucose in 250 300 ml of water within five min and a second blood sample was collected after 2 hrs for determination of 2h plasma glucose level (2hPG). The standard tests were repeated on 37 of 60 known diabetic patients to confirm the reproducibility of the tests. A second GTT was performed 8 weeks later. Blood glucose levels were measured by glucose-oxidase enzymatic method. According to the WHO criteria, individuals with 2hPG levels 200 mg are considered diabetics. 12 In addition, according to the American Diabetic Association (ADA) criteria, patients with FPG levels 126 mg/dl were evaluated as diabetic. 13 In comparison with WHO criteria (2hPG 200), sensitivity, specificity, positive and negative predictive values (PPV and NPV) were calculated for each of the factors evaluated. The following preconditions were applied to the screening method in order to achieve the desired objective. 1) High sensitivity as compared to WHO criteria (>80%). 2) Low prevalence rates (<50%) of the variables or high specificity (>50%) in the population under study. The comparison group included 60 sex- and agematched individuals selected from 961 normal subjects. Student t test was used to compare variables between two groups. Statistical analysis Data are presented as mean±sd. Unpaired Student t test was used to compare variables between the two groups. A p value <0.05 was considered statistically significant. 22

Evaluation of different risk factors for early diagnosis of diabetes mellitus 70 60 Control Diabetic 50 Percent 40 30 20 10 0 P<0.005 P<0.001 P<0.03 P<0.001 Truncal obesity Age 50 years History of gestational diabetes Obesity 2 (BMI 30 kg/m) Diabetes history in first order relatives Glycosuria Fig 1: Relative prevalence rates of major risk factors in normal and diabetic subjects Results Prevalence: Out of 1021 cases studied, 60 new diabetic patients (5.9%) were found. Fifty-two (87%) and 39 patients (65%) were diagnosed by means of 2hPG and FPG, respectively. The FPG in nine patients were between 100 110 mg/dl and in four cases it was <100 mg/dl. Correlation coefficient (r) between FPG and 2hPG was 0.762 for all subjects (p<0.001). The following linear relation between FPG and 2hPG was discovered in the 60 newly diagnosed diabetic patients: FPG = 46.83 + 0.73 2hPG, (R 2 =0.68). Reproducibility of the test was 84% (31 out of 37) with 2hPG and 67% (25 out of 37) with FPG. Comparative study of diabetics and normal subjects: The female to male ratio was 1.33. Among 1021 cases studied, 53.7%, 37.0% and 9.3% aged 30 44, 45 59 and >59 years, respectively. The corresponding ratios for the diabetic group were 23.3%, 46.75% and 30.0%, respectively. Overall, 28.7% of normal and 55% of diabetic subjects aged >49 years. Values of the quantitative variables for 60 normal and 60 DM cases are shown in Table 1. Significant differences between the two groups were observed for BMI (p<0.02), FPG (p<0.001) and 2hPG (p<0.001). Relative prevalence rates of risk factors for cardiovascular disease in the two groups are demonstrated in Fig 1. Significant statistical differences were found for factors such as truncal obesity (p<0.005), obesity (p<0.03), ages of 50 years (p<0.001) and detection of glucose in urine (p<0.001). A significant difference (p<0.001) was also found between the two groups for detection of glucose in urine. Values of different factors for screening: Among all the indices studied, 6 indices including truncal obesity, age 50 years, obesity, history of gestational diabetes (only in Table 1: BMI, WHR, blood pressure, FPG and 2hPG in normal and diabetic subjects Variables Normal subjects (n=60) Diabetics (n=60) Mean±SD 95% CI* Mean±SD 95% CI BMI (Kg/m 2 ) 27.3±3.8 26.3-28.3 29.2±4.0 28.1-30.2 WHR 0.89±0.07 0.87-0.91 0.90±0.07 0.88-0.92 Systolic BP (mm Hg) 133±20 128-138 132±17 127-136 Diastolic BP (mm Hg) 81.2±9.9 78.6-83.7 80.3±8.7 78.1-82.6 FPG (mg/dl) 89.2±9.4 86.7-91.6 148±48.1 135-160 2hPG (mg/dl) 113±28.7 105-120 250±69 232-268 * CI: Confidence interval for mean p<0.001, p<0.02, compared to normal subjects 23

S. Habibi Moeini, P. Mirmiran, Y. Mehrabi, F Azizi Table 2: Performance characteristics of variables obtained by the standard diagnostic method for diabetes, recommended by WHO Variables Sensitivity (%) Specificity (%) PPV (%) NPV (%) Truncal obesity 66.7 54.5 8.4 91.6 Age 50 years 55.0 72.9 11.3 96.3 BMI 30 Kg/m 2 43.3 74.2 9.6 95.4 Glycosuria 38.0 99.0 68.8 96.3 History of gestational diabetes 21.4 85.4 7.1 95.5 History of DM in relatives 30.0 78.0 7.9 94.7 women), diabetes history in first order relatives and glycosuria showed the highest values for the screening tests. In Table 2, sensitivity, specificity and PPV and NPV of the six aforementioned indices are compared with the standard diagnostic method recommended by WHO. The highest and lowest rates of sensitivity belonged to truncal obesity and history of GDM respectively. Men and women were divided into four groups according to the age and sex (i.e., women <50 years, women aged 50 years, men <50 years and men aged 50 years). Table 3 shows the sensitivity, specificity, PPV and NPV of the test, when at least one and two variables were positive for the four groups. When glycosuria was excluded, no significant changes in performance characteristics occurred. In Table 4, the standard diagnostic method of diabetes is compared in terms of sensitivity, specificity, PPV and NPV when age 50 years and above was considered as a risk factor for DM. The diagnostic methods used for this Table were based upon at least one or two positive clinical indices, excluding glycosuria index. When BMI of 27, instead of 30 kg/m 2 and age of 45 instead of 50 years were employed, the sensitivity and specificity of variables could not be used for diagnosis. Discussion This study demonstrated that OGTT rather than fasting blood glucose is the most reliable method for the diagnosis of the undetectable diabetes mellitus. The major finding of the present investigation is that diagnostic risk factors for detection of DM are not useful for patients aged 50 years. People aged <50 years, men with at least one risk factor and women with at least two risk factors, were the most appropriate candidates for performing OGTT. The prevalence rate of 5.9% for newly diagnosed diabetes in subjects >30 years is similar to the results obtained from other populations. 14 In the present study, 2hPG test had a higher sensitivity (87%) as compared to the FPG (65%) for the diagnosis of DM. About one-third of diabetic patients could not be diagnosed with FPG as recommended by ADA criteria. The expert committee proposed that individuals with an FPG <110 mg/dl is considered as normal and stated that FPG had a higher reproducibility than 2hPG. 13 However, 15% of diabetic patients enrolled in this study had FPG <100 mg/dl and their 2hPG showed a much higher reproducibility than FPG. It is possible that an inappropriate time interval between the last meal and collection of samples for measurement of FPG, could result in less reproducibility, while inappropriate interval had less negative influence on the 2hPG test. Comparison of the normal and diabetic groups revealed that 27% of the normal individuals aged 50 years, and 55% of the diabetic patients were classified in this age group. This is consistent with the findings of other studies, 14 that the increment of age was a risk factor for type 2 DM. The evaluation of data for different variables revealed that truncal obesity had the highest and history of gestational diabetes had the lowest sensitivity, respectively. In addition, glycosuria showed the highest specificity. Therefore, none of these variables per se could be used as a reliable diagnostic tool. The Expert Committee recommended that all populations' aged 45 years should take the FPG test, while those <45 years should be screened for other risk factors. 13 Our survey also revealed the importance of detecting risk Table 3: Performance characteristics of the positive results of at least one variable and two variables obtained by the standard diagnostic method for diabetes, recommended by WHO Sex / Age (years) Sensitivity (%) Specificity (%) PPV (%) NPV (%) 1 * 2 1 2 1 2 1 2 Women < 50 91.7 75.0 26.0 63.0 3.1 5.0 99.2 99.0 Women 50 94.1 70.6 7.8 47.8 16.2 20.3 87.5 89.6 Men < 50 86.7 60.0 53.6 87.5 10.7 23.7 98.4 97.1 Men 50 75.0 50.0 40.7 84.3 10.8 23.5 94.4 94.6 * 1: At least one variable; 2: At least two variables 24

Evaluation of different risk factors for early diagnosis of diabetes mellitus Table 4: Performance characteristics of the positive results with at least one or two variables obtained by the standard diagnostic method for diabetes, recommended by WHO No. of variables & sex Sensitivity (%) Specificity (%) PPV (%) NPV (%) Women with at least one factor 96.6 21.8 6.1 99.2 Women with two factors 82.7 54.5 8.8 98.4 Men with at least one factor 90.3 31.3 9.2 97.7 Men with two factors 54.8 68.2 11.7 95.1 factors in individuals aged <50 years (one risk factor for men, two risk factors for women). However, based on the present findings, this method could not be recommended for those aged 50 years. In conclusion, with respect to the results of this survey, the following methods can be recommended for national programs: The most reliable method for the detection of undiagnosed cases of DM is the measurement of plasma glucose levels 2 hours after glucose intake (2hPG). In men <50 years of age one positive risk factor and in women <50 years, two positive risk factors are the most reliable and effective methods to use for the screening of early diagnosis of type 2 DM. However, the employment of risk factors as a screening method for individuals aged 50 years is not appropriate and application of 2hPG after OGTT is therefore recommended for this age group. References 1 King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21: 1414-1431. 2 Nicolussi A., Carinci F, Ciampi A: Stratifiying patients at risk of diabetic complications.diabetes Care 1998;21: 1439-1444. 3 Bild DE, Selby JV, Sinnock P, et al: Lower-extremity amputation in people with diabetes: epidemiology and prevention. Diabetes Care 1989;12:24-31 4 Garcia M., McNamara J., Goijon T, et al: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 1994;23:105-11. 5 Klein R., Klein BED., Moss SE: Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996;124:90-96. 6 Moeini S, Sheikholeslami FH. Navai L., Azizi F: Prevalence of micro-and macrovascular complication of diabetes. Proceeding of the 10th AOCE, Beijing, China, Oct 30th-Nov 3rd, 1994. 7 Larijani B, Bastanhagh M, Pajouhi M, et al. Prevalence of NIDDM in Tehran. Proceedings of the Third International congress on Endocrine Disorders, Tehran, September 4-8, 1995. 8 Amini M, Afshin-Nia F, Bashardous N, et al: Prevalence and risk factors of diabetes mellitus in the Isfahan city population (aged 40 or over) in 1993. Diabetes Res Clin Practive 1997;38:185-190, 9 Azizi F: Diabetes Mellitus in the Islamic Republic of Iran. IDF Bulletin 1996;41:38-9. 10 Azizi F: Diabetes Mellitus in the Islamic Republic of Iran. Assignment Report, WHO-EMRO, Dec. 1 & 7-23, 1996. 11 Engelgau MM, Thompson TJ, Aubert RE: Herman WH. Screening for NIDDM in nonpregnant adults: A review of Principles, screening tests, and recommendations. Diabetes care 1995;18:1606-18. 12 Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consulation, WHO, Geneva, 1999. 13 American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20: 1183-1197. 14 Harris MI, Flegal JM, Cowie CC, et al: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care 1998;21: 518-524. 25